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The cytokine erythropoietin (EPO) has long been recog-
nized as the principal hormonal regulator of erythropoiesis, 
stimulating the growth and promoting the differentiation of 
early erythroid progenitor cells [1]. In the adult, this cytokine 
is produced mainly by the kidney, and is secreted into the 
blood circulation to reach the bone marrow [2]. There, EPO 
binds to the cognate EPO receptor (EPOR) on erythroid 
progenitor cells, thus preventing apoptosis and stimulating 
their differentiation and maturation into erythrocytes [3]. 
The expression of Epo is oxygen-regulated, and is induced by 
hypoxia-inducible factors when tissue oxygenation is reduced 
[4]. Therefore, EPO secretion increases under hypoxic condi-
tions, eventually resulting in an increase in the hematocrit [5].
The source of Epo expression is not limited to the kidney. 
In fact, about 10% of EPO found in the bloodstream is of 
non-renal origin [6]. Numerous tissues, including the brain, 
have been identified as secreting EPO (reviewed in [7]). Simi-
larly, EpoR expression is broader than originally reported, 
being present in, among others, the brain, heart, and liver 
[8]. Expression of Epo and EpoR has also been found in the 
retina [9,10]. The widespread tissue distribution of EPOR 
proposes that the antiapoptotic effects of EPO may go well 
beyond the prosurvival effects on early erythroid progenitors. 
In fact, the tissue-protective abilities of this cytokine have 
been demonstrated in various experimental injury models 
over the last few years. For example, exogenous application of 
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Purpose: Erythropoietin (EPO) was originally described for its antiapoptotic effects on erythroid progenitor cells in 
bone marrow. In recent years, however, EPO has also been shown to be cytoprotective in several tissues, including the 
retina. There, exogenous application of EPO was reported to exert neuro- and vasoprotection in several models of retinal 
injury. EPO and the erythropoietin receptor (EPOR) are expressed in the retina, but the role of endogenous EPO-EPOR 
signaling in this tissue remains elusive. Here, we investigated the consequences for cell physiology and survival when 
EpoR is ablated in rod photoreceptors or in the peripheral retina.
Methods: Two mouse lines were generated harboring a cyclization recombinase (CRE)-mediated knockdown of EpoR 
in rod photoreceptors (EpoRflox/flox;Opn-Cre) or in a heterogeneous cell population of the retinal periphery (EpoRflox/
flox;α-Cre). The function of the retina was measured with electroretinography. Retinal morphology was analyzed in 
tissue sections. The vasculature of the retina was investigated on flatmount preparations, cryosections, and fluorescein 
angiography. Retinal nuclear layers were isolated by laser capture microdissection to test for EpoR expression. Gene 
expression analysis was performed with semiquantitative real-time PCR. To test if the absence of EPOR potentially 
increases retinal susceptibility to hypoxic stress, the knockdown mice were exposed to hypoxia.
Results: Newborn mice had lower retinal expression levels of EpoR and soluble EpoR (sEpoR) than the adult wild-type 
mice. In the adult mice, the EpoR transcripts were elevated in the inner retinal layers, while expression in the photore-
ceptors was low. CRE-mediated deletion in the EpoRflox/flox;Opn-Cre mice led to a decrease in EpoR mRNA expression 
in the outer nuclear layer. A significant decrease in EpoR expression was measured in the retina of the EpoRflox/flox;α-Cre 
mice, accompanied by a strong and significant decrease in sEpoR expression. Analysis of the retinal morphology in the 
two knockdown lines did not reveal any developmental defects or signs of accelerated degeneration in the senescent 
tissue. Similarly, retinal function was not altered under scotopic and photopic conditions. In addition, EpoR knockdown 
had no influence on cell viability under acute hypoxic conditions. Retinal angiogenesis and vasculature were normal in 
the absence of EPOR. However, expression of some EPOR-signaling target genes was significantly altered in the retinas 
of the EpoRflox/flox;α-Cre mice.
Conclusions: Our data suggest that expression of EPOR in rod photoreceptors, Müller cells, and amacrine, horizontal, 
and ganglion cells of the peripheral retina is not required for the maturation, function, and survival of these cells in aging 
tissue. Based on the expression of the EPOR-signaling target genes, we postulate that expression of soluble EPOR in the 
retina may modulate endogenous EPO-EPOR signaling.
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EPO protected kidney and heart cells against injury provoked 
by ischemia reperfusion [11-13], and was neuroprotective in 
different brain injury models [14]. Neuroprotective effects of 
EPO have also been reported in the retina, including protec-
tion of retinal ganglion cells (RGCs) in experimental degener-
ative models [15-18], as well as preservation of photoreceptor 
survival after light exposure [19]. Much research effort has 
been put into elucidating the ability of exogenous applica-
tions of EPO to prevent cell death in view of the potential use 
of this cytokine as a therapeutic agent against degenerative 
diseases. However, the function of endogenous EPO-EPOR 
signaling in extrahematopoietic tissues, including the retina, 
has not yet been fully clarified. This is in part due to the 
embryonic lethal phenotype of Epo null and EpoR null mice, 
which die in utero because of impaired production of mature 
red blood cells [20,21].
In the brain, EPOR is thought to be required for neural 
progenitor cell (NPC) proliferation and thus for correct 
brain development. In fact, lack of EpoR results in severe 
impairment in embryonic neurogenesis [22,23]. A similar 
mechanism might be present in the developing retina; that is, 
EPO-EPOR signaling may be essential for retinal progenitor 
cell (RPC) proliferation, in particular during the period of 
physiologic hypoxia in postnatal retinal development [24]. 
In addition to neuroprotection, EPO-EPOR signaling has 
been linked to developmental angiogenesis through angio-
genic and vasoprotective properties [25]. Deletion of Epo or 
EpoR in mice severely affected angiogenesis and resulted in 
reduced complexity of the vessel networks, characterized by 
narrower vessel diameter and reduced vascular branching 
[26]. Consequently, the absence of EPO-EPOR signaling 
in the early postnatal mouse retina could potentially impair 
angiogenesis. To address these questions, we generated a 
conditional knockdown mouse line lacking the EpoR gene 
in a heterogeneous cell population of the retinal periphery. 
We show that the absence of EPOR did not result in overt 
defects in maturation, angiogenesis, and function of the 
peripheral retina in these mice, and that the tissue survived 
acute hypoxic exposure.
EPO-EPOR signaling may be implicated not only in 
retinal development but also in the ability of retinal cells 
to cope with chronic stress, which could impair long-term 
survival. In the adult retina, EPO and EPOR expression 
follows a circadian rhythm, with increased protein levels 
before the onset of daily light [27]. This expression pattern 
hints at a possible role of EPO-EPOR signaling in coping 
with increased phototoxic stress during the day. To test 
whether rod-specific EpoR expression is necessary for long-
term photoreceptor survival, we generated a conditional 
knockdown mouse line with a rod-specific ablation of EpoR. 
We found that expression of EPOR is not necessary for the 
function and survival of rod photoreceptors.
METHODS
Animals and genotyping: All animal experiments were 
conducted according to the regulations of the Cantonal 
Veterinary Authority of Zurich and the statement of the Asso-
ciation for Research in Vision and Ophthalmology (ARVO) 
for the use of animals in ophthalmic and vision research. 
All mice were kept at the animal facility of the University 
Hospital Zurich in a 12 h:12 h light-dark cycle with food and 
water ad libitum. Light was maintained at 60 lux at cage level 
during the light period. Mice were euthanized by CO2 inhala-
tion followed by cervical dislocation. All experiments were 
conducted with a minimum of n = 3 mice for each time point 
and condition.
Conditional EpoR knockdowns were generated by 
breeding EpoRflox/flox mice [23] carrying loxP sites in exons 
1 and 4 of EpoR either to mice expressing Cre recombinase 
under control of the α-element of the Pax6 promoter (α-Cre) 
[28] resulting in EpoRf lox/f lox;α-Cre double mutant animals 
or to mice expressing Cre recombinase under control of the 
rhodopsin promoter (Opn-Cre) [29] resulting in EpoRf lox/
flox;Opn-Cre double mutant mice. EpoRflox/flox littermates were 
used as controls. All mice were on a mixed BL/6;129S6 back-
ground and homozygous for the Rpe65450Leu allele. C57BL/6 
mice were used to analyze postnatal gene expression. To 
investigate the spatial expression pattern of Cre recombinase 
in the α-Cre retina, α-Cre mice were crossed to Ai6 reporter 
mice (stock number: 007,906, Jackson Laboratory, Bar 
Harbor, ME) that express ZSGREEN upon CRE-mediated 
recombination of a floxed STOP cassette [30]. The retinas 
were cryosectioned and analyzed for native ZSGREEN 
expression with fluorescent microscopy. Spatial activity of 
CRE recombinase in the Opn-Cre mice has been previously 
reported [31]. The mice were genotyped using genomic DNA 
isolated from ear biopsies with conventional PCR using the 
following conditions: initial denaturation (95 °C, 5 min); 35 
cycles of denaturation (95 °C, 45 s), annealing (temperature 
see Table 1, 45 s) and elongation (72 °C, 45 s); and final exten-
sion (72 °C, 10 min). Primer pairs and annealing conditions 
are shown in Table 1. PCR products were run on a 1.5% 
agarose gel for size detection.
RNA isolation, cDNA synthesis, and semiquantitative real-
time PCR: Retinas were isolated through a corneal incision 
and immediately snap frozen in liquid nitrogen. Total RNA 
was isolated using the RNeasy isolation kit (RNeasy, cata-
logue number: 74,104; Qiagen, Hilden, Germany) or the High 
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Pure RNA isolation kit (catalogue number: 11,828,665,001; 
Roche Diagnostics, Basel, Switzerland). Residual genomic 
DNA was removed by an incubation step with DNase. RNA 
(650 ng or 1000 ng) was reverse transcribed using oligo(dT) 
and M-MLV reverse transcriptase (catalogue number: 
M1701; Promega, Madison, WI). Ten nanograms of cDNA 
were used for gene expression analysis with semiquantitative 
real-time PCR using a LightCycler 480 instrument (Roche 
Diagnostics), the LightCycler 480 SYBR Green I Master 
kit (catalogue number: 04,887,352,001; Roche Diagnostics), 
and specific primer pairs (Table 2). The primer pairs were 
designed to span large intronic sequences or to cover exon-
exon boundaries. Gene expression was normalized to actin 
beta (Actb), and relative quantification was calculated using 
the comparative threshold method (ΔΔCT) and Light Cycler 
480 software (Roche Diagnostics).
Histology and light microscopy: To analyze retinal 
morphology with light microscopy, the eyes were enucleated 
and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer 
(pH 7.3) at 4 °C overnight. After fixation, the cornea and 
the lens were removed, and the eyecup was separated into 
a superior half and an inferior half by cutting through the 
optic nerve head. Trimmed tissue was washed in cacodylate 
buffer, contrasted with osmium tetroxide (1%, 1 h, room 
temperature), dehydrated by incubation in increasing ethanol 
concentrations, and embedded in Epon 812. Semithin sections 
(0.5 μm) were prepared and counterstained with toluidine 
blue. An Axioplan digitalized microscope (Zeiss Meditec, 
Jena, Germany) was used to examine the slides. Retinal 
thickness from the nerve fiber layer to the RPE was measured 
at fixed distances from the optic nerve head (ONH) using 
ImageJ (software version 1.43; developed by Wayne Rasband, 
National Institutes of Health, Bethesda, MD; available NIH).
Immunofluorescence on retinal cryosections: For immu-
nofluorescence, the eyes were enucleated and fixed in 4% 
paraformaldehyde (PFA) at 4 °C overnight. The cornea and 
the lens were removed, and the eyecups were incubated in 
30% sucrose in phosphate buffered saline (PBS; 1X; 137 mM 
NaCl, 2.7 mM KCl, 81 mM Na2HPO4, 19 mM NaH2PO4, pH 
7.4) for cryoprotection until the tissue sunk to the bottom 
of the tube. The tissue was then embedded in tissue cryo-
protective medium (catalogue number: 14,020,108,926 Leica 
Microsystems Nussloch, Nussloch, Germany) and rapidly 
frozen in a 2-methylbutane bath cooled with liquid nitrogen. 
Twelve-micrometer-thick sections were cut through the 
optic nerve head on a Cryostat (Leica), air-dried, and stored 
at −80 °C until further use. Sections on slides were incubated 
with blocking solution (3% horse serum in PBS/0.3% Triton 
X-100) for 1 h at room temperature. Primary antibodies 
were applied in blocking solution overnight at 4 °C (Table 
3). The slides were washed three times with PBS and incu-
bated with Cy2- or Cy3-conjugated secondary antibodies 
(Jackson ImmunoResesarch, Soham, UK) in blocking solu-
tion (dilution 1:500) for 1 h at room temperature. To stain 
the blood vessels, cryosections were incubated overnight at 
4 °C with G. simplicifolia isolectin IB4-Alexa 594 (1:200; 
catalogue number: I21413; Invitrogen, Basel, Switzerland) 
in blocking solution. After three washing steps in PBS, the 
cell nuclei were stained with 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI), and the slides were mounted with 
antifade medium (10% Mowiol 4–88 (vol/vol); Calbiochem, 
San Diego, CA) in 100 mM Tris (pH 8.5), 25% glycerol (wt/
vol), and 0.1% 1,4-diazabicyclo [2.2.2] octane [DABCO]). 
Immunofluorescently labeled proteins were visualized using 
an Axioplan fluorescence microscope (Zeiss).
Staining of blood vessels on retinal flatmounts: Eyes were 
enucleated and incubated in 2% PFA in PBS for 5 min. Subse-
quently, the cornea and the lens were removed, and the retina 
was carefully separated from the eyecup. The retina was cut 
into a “clover-leaf” shape, fixed in methanol (−20 °C), and 
post-fixed in 4% PFA in PBS for 10 min. The flatmounted 
retinas were washed briefly with PBS and placed in blocking 
solution (1% fetal calf serum, 0.1% Triton X-100 in PBS) 
for 1 h. The retinas were incubated overnight at 4 °C with 
G. simplicifolia isolectin IB4-Alexa 594 (1:100, catalogue 
number: I21413; Invitrogen) in blocking solution. The retinal 
flatmounts were washed with PBS and mounted using anti-
fade medium (see above). Imaging was performed using a 
digitalized light microscope (Axiovision, Zeiss).
Fluorescein angiography: The mice pupils were dilated 
with 1% Cyclogyl (Alcon, Cham, Switzerland) and 5% 
phenylephrine (Ciba Vision, Niederwangen, Switzerland) 1 
h before angiography. Mice were anaesthetized with 2.2 µl/g 
bodyweight of a ketamine/xylazine mix (51/6 mix, subcuta-
neous injection) 5–10 min before angiography. Eyes were kept 
moisturized with hydroxypropylmethylcellulose (Methocel 
2%, Omnivision, Puchheim, Germany). For f luorescein 
angiography, 50 µl of 0.2% fluorescein solution (AK Fluor, 
Akorn, Lake Forest, IL) were injected intraperitoneally, and 
the retinal vasculature was analyzed with the Micron III 
retinal imaging system (Phoenix Research Labs, Pleasanton, 
CA).
Electroretinography: Electroretinograms (ERGs) were 
recorded according to a previously described procedure 
[32,33]. The ERG equipment consisted of a Ganzfeld bowl, a 
direct current amplifier, and a PC-based control and recording 
unit (LKC UTAS-E 3000, LKC Technologies, Hellendorn, 
the Netherlands). Mice were dark adapted overnight and 
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anesthetized with ketamine (66.7 mg/kg bodyweight) and 
xylazine (11.7 mg/kg bodyweight). The pupils were dilated, 
and single-flash ERG responses were obtained under dark-
adapted (scotopic) and light-adapted (photopic) conditions. 
Light adaptation was accomplished with a background illu-
mination of 30 cd/m2 starting 5 min before recording. Single 
white-flash stimulus intensity ranged from –3.7 to 1.9 log cd 
· s/m2 under scotopic and from –0.6 to 2.9 log cd · s/m2 under 
photopic conditions, divided into ten and eight steps, respec-
tively. Ten responses were averaged with an interstimulus 
interval (ISI) of either 4.95 s (for –3.7, –3, –2.6, –2, −1.6, –1, 
–0.6, −0.02, 0.4, and 0.9 log (cd · s/m2)) or 16.95 s (for 1.4, 1.9, 
2.4, and 2.9 log (cd · s/m2)).
Laser capture microdissection: The eyes were enucleated, 
immediately embedded in tissue freezing medium (catalogue 
number: 14,020,108,926; Leica Microsystems Nussloch), and 
frozen in a 2-methylbutane bath cooled with liquid nitrogen. 
Retinal sections (20 μm) were fixed (5 min in acetone), air 
dried (5 min), and dehydrated (30 s in 100% ethanol, 5 min 
in xylene). Microdissection was performed using an Arcturus 
XT Laser capture device (Molecular Devices, Sunnyvale, 
CA). RNA was isolated using the Arcturus kit for RNA 
isolation (catalogue number: KIT0204; Molecular Devices) 
according to the manufacturer’s directions including a DNase 
treatment to digest residual genomic DNA. Equal amounts of 
RNA were used for reverse transcription using oligo(dT) and 
M-MLV reverse transcriptase (Promega).
Hypoxic exposure: The mice were exposed to reduced oxygen 
levels in a hypoxic chamber (In Vivo cabinet Model 30; 
Coy Laboratory Products, Grass Lake, MI) equipped with 
an oxygen controller (Coy Laboratory Products). During 
hypoxia, mice had access to food and water ad libitum. By 
altering the O2:N2 ratio, oxygen levels were reduced to the 
desired concentration in 2% steps over 1 h. Mice were kept 
at 7% O2 for 6 h. To analyze the gene and protein expression, 
the retinas were isolated immediately after the hypoxic period 
and processed for further analysis. To investigate the retinal 
morphology, the eyes were enucleated 12 days after hypoxic 
exposure.
Statistical analysis: Statistical analysis was performed using 
Prism 4.0 software (GraphPad, San Diego, CA). All data are 
presented as mean ± standard deviation (SD). The number of 
samples (n) used for individual experiments is given in the 
figure legends. Statistical differences of means were calcu-
lated using the Student t test. Differences with p values below 
0.05 were considered significant.
RESULTS
Expression of Epo and EpoR isoforms in the retina: EpoR 
expression is elevated in the embryonic brain and decreases 
into adulthood [22]. A similar situation may be present in 
the retina. Thus, we analyzed the expression profile of Epo 
and EpoR in the newborn and adult retinas of C57BL/6 
wild-type mice with semiquantitative real-time PCR. Epo 
was expressed in the newborn retina as early as P3 (Figure 
1A). Starting at P10, the expression levels increased by about 
two- to threefold, reaching more or less steady-state levels in 
the adult retina (Figure 1A). Similarly, the mRNA levels of 
EpoR were maintained at moderately low levels up to P10, 
the time point when expression increased by sevenfold to 
reach a 14-fold increase at 6 months of age (Figure 1B). The 
EpoR gene can be expressed through alternative splicing as 
a membrane-bound (referred to as “EpoR” in the text) and a 
soluble isoform (soluble EpoR (sEpoR)), which encodes for 
the extracellular domain of EPOR [34-36]. The expression 
of this isoform has not yet been reported in the retina. To 
measure the expression of EpoR and sEpoR, we designed 
primers specific to each isoform (Appendix 1). Interestingly, 
Table 3. anTibodies for immunofluoresCenCe on reTinal CryoseCTions.
Protein Host Supplier Cat-nr Dilution
CALB1 rabbit Chemicon, Billerica, MA 1778 1:500
CALB2 rabbit Chemicon, Billerica, MA 5054 1:1000
GFAP mouse Sigma, St. Louis, MO G3893 1:500
GNAT1 rabbit Santa Cruz Biotechnology; Santa Cruz, CA sc-389 1:500
GNAT2 rabbit Santa Cruz Biotechnology; Santa Cruz, CA sc-390 1:500
GLUL (GS) mouse Millipore, Billerica, MA B302 1:500
PKCA rabbit Sigma, St. Louis, MO 4334 1:1000
POU4F1 
(BRN3A) mouse Chemicon, Billerica, MA 1585 1:100
RPE65 rabbit Pineda Antibodies, Berlin, Germany Pin-5 1:500
VSX2 (CHX10) rabbit generous gift of C. Cepko, Harvard University, MA - 1:500
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the expression profile of sEpoR was similar to the membrane-
bound isoform; that is, it was detectable at low levels up to 
P10, the time point when expression increased about tenfold 
and reached approximately 20-fold higher levels in the adult 
retina (Figure 1C). The EPOR not only forms homo-oligomers 
but has also been suggested to form hetero-oligomers with the 
beta common receptor (Csf2rb (βCR)) [37,38]. In contrast to 
EpoR, expression of Csf2rb (βCR) remained at steady-state 
levels in the retina throughout the analyzed period (Figure 
1D).
In addition to elucidating the temporal expression profile 
of EpoR, we also analyzed the spatial expression pattern in 
the retinal tissue to test EpoR expression in specific retinal 
layers. For this purpose, we isolated individual layers (the 
outer nuclear layer [ONL], the inner nuclear layer [INL], the 
ganglion cell layer [GCL]) of 12-week-old EpoRflox(flox mice 
by laser capture microdissection. Analysis of the expression 
of marker genes for the individual retinal layers showed high 
purity of the isolated tissue with only a little cross contami-
nation (Appendix 2). EpoR transcripts were detected mainly 
in the GCL and the INL, with markedly lower levels in the 
ONL, thus suggesting low expression of EpoR in photorecep-
tors (Figure 2).
Knockdown of EpoR in rod photoreceptors or in cells of the 
retinal periphery has no effect on their development, function, 
and survival: To explore the possible functions of endogenous 
EPO-EPOR signaling in the retina, we generated two mouse 
strains bearing a knockdown of EpoR in specific retinal cell 
populations. We ablated loxP-flanked exons 1–4 of the EpoR 
genomic sequence either in rod photoreceptors, by generating 
EpoRf lox/f lox;Opn-Cre mice, or in an assorted population of 
neurons and glia of the retinal periphery by generating EpoR-
flox/flox;α-Cre mice. Note that the lack of exons 1–4 affects the 
expression of not only EpoR but also sEpoR (Appendix 1).
By using reporter mouse lines [30,39], we assessed the 
specificity and localization of CRE-mediated recombination. 
Figure 1. Gene expression profile in 
the retinas of wild-type mice. Rela-
tive expression of erythropoietin 
(Epo; A), erythropoietin receptor 
(EpoR; B), soluble erythropoietin 
receptor (sEpoR; C), and beta 
common receptor (Csf2rb (βCR); D) 
as measured with semiquantitative 
real-time PCR on cDNA samples 
prepared from the total retinas of 
the C57BL/6 mice at the postnatal 
days as indicated. All values were 
normalized to actin beta (Actb), and 
the value at P3 was set to 1. Shown 
are the mean ± standard deviation 
(SD) of n = 3 animals.
Figure 2. Expression of EpoR in the retinal nuclear layers. Semi-
quantitative real-time PCR after laser capture microdissection 
showed relative EpoR mRNA levels in the different retinal layers 
(as indicated) of the EpoRflox/flox control mice. Values were normal-
ized to actin beta (Actb) and expressed relative to the value in the 
ONL, which was set to 1. Shown are the mean ± standard deviation 
(SD) of at least two mice amplified in duplicate. ONL, outer nuclear 
layer; INL, inner nuclear layer; GCL, ganglion cell layer. 
Molecular Vision 2014; 20:307-324 <http://www.molvis.org/molvis/v20/307> © 2014 Molecular Vision 
314
Although Opn-Cre-mediated recombination was specific 
for the ONL, expression of CRE was patchy and detected 
in approximately 40% of the total rod population (qualita-
tive estimation) as previously reported [31]. CRE-mediated 
recombination in the α-Cre mouse was detected in a mixed 
cell population of the retinal periphery and a smaller subset of 
cells in the central retina (Appendix 3 [40]). Immunostaining 
with antibodies specific for different retinal cells suggested 
CRE activity in the Müller glia cells, rod photoreceptors, 
and horizontal, amacrine, and a subset of ganglion cells 
(Appendix 3). Whereas in Opn-Cre mice, recombination of 
floxed sequences was maximal only around 10 weeks of age 
(not shown), CRE activity in α-Cre mice showed early onset 
at E10.5 [41].
At the genomic level, Opn-Cre and α-Cre success-
fully deleted loxP-flanked exons 1–4 in the EpoR gene as 
evidenced by the appearance of a 220 bp fragment (Figure 
3A) that was amplified from recombined genomic DNA 
when the respective specific primers for PCR were used 
(Table 1) [23]. To assess the knockdown at the mRNA 
level, we performed semiquantitative real-time PCR on the 
total retinal RNA. A statistically significant (p<0.05) 35% 
decrease in EpoR mRNA expression was measured in the 
retinas of the EpoRflox/flox;α-Cre mice (Figure 3B). However, 
the decrease in EpoR mRNA was not significant in the 
EpoRflox/flox;Opn-Cre mice at P84. This was unexpected, but 
since the total retinal RNA was used for analysis, the effect 
of a cell-specific knockout may have been masked by cells 
that did not undergo recombination, especially if those cells 
(e.g., in the INL and the GCL) expressed the gene at much 
higher levels (Figure 2). Consequently, we isolated RNA 
from individual retinal nuclear layers (the ONL, INL, GCL) 
separated by laser capture microdissection. Amplification of 
specific marker genes for each nuclear layer suggested high 
purity of the isolated layers (Appendix 2). Gene expression 
analysis showed an EpoR expression level in the ONL of 
EpoRf lox/f lox;Opn-Cre mice that was reduced by about 35% 
compared to the control littermates, even though the knock-
down did not reach statistical significance (Figure 3C). This 
efficiency of EpoR knockdown was similar to the fraction of 
photoreceptors that express Cre recombinase in the Opn-Cre 
mouse retina [29,31]. Although the knockdown efficiency 
was not high when calculated on the level of the total retina 
or the ONL (cells without active CRE still express EpoR), 
most Cre-expressing cells (e.g., 30–40% of rods) should have 
recombined floxed sequences on both alleles leading to many 
cells harboring a complete knockout and therefore lacking the 
EPOR protein. Due to the lack of reliable antibodies [42,43], 
the EPOR protein levels and tissue distribution were not 
analyzed with western blotting or immunofluorescence.
Figure 3. Knockdown of EpoR in the EpoRflox/flox;Opn-Cre and EpoRflox/flox;α-Cre retinas. A: PCR amplification of genomic DNA isolated 
from the retinas of EpoRflox/flox, EpoRflox/flox;Opn-Cre, and EpoRflox/flox; α-Cre mice at P84 (n = 3). CRE-mediated recombination resulted in 
the amplification of a 220 bp fragment. B: Semiquantitative real-time PCR analysis of the expression of EpoR in total retinal RNA from the 
EpoRflox/flox;α-Cre mice (blue bar) and the EpoRflox/flox mice (white bar) at P84. Values were normalized to actin beta (Actb), and the EpoRflox/
flox values were set to 1. Shown are the mean ± standard deviation (SD) of n = 4 animals. C: Semiquantitative real-time PCR analysis of EpoR 
levels in different retinal layers separated by laser capture microdissection from the EpoRflox/flox (white bars) and EpoRflox/flox;Opn-Cre mice 
(red bars). Values were normalized to actin beta (Actb) and expressed relative to the value of EpoRflox/flox mice for each layer, which were 
set to 1. Shown are the mean ± SD of at least two mice. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. The 
differences in gene expression levels between the knockdown and control mice were tested for significance using a Student t test. *: p<0.05. 
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The absence of EPOR results in increased apoptosis of 
NPCs and thus affects brain development [22]. Since α-Cre 
mice recombine f loxed sequences in embryonic retinal 
progenitor cells, the absence of or reduced levels of EPOR 
may lead to developmental defects and thus to morphological 
alterations in the adult retina. However, histological analysis 
did not reveal tangible signs of developmental defects, and 
normal morphology was observed up to 1 year of age in the 
retinal periphery of the EpoRflox/flox;α-Cre mice (Figure 4A). 
Similarly, the retina and in particular the photoreceptors of 
the EpoRf lox/flox;Opn-Cre mice showed normal morphology 
up to 1 year of age (Figure 4A). Analysis of the expression 
of rhodopsin (Rho), guanine nucleotide binding protein, 
alpha transducin 2 (Gnat2), visual system homeobox 2 Vsx2 
(Chx10), and POU domain, class 4, transcription factor 1 
Pou4f1 (Brn3a) indicated that the number of rods, cones, 
bipolar cells, and RGCs, respectively, was not affected in the 
EpoR knockdown mice up to 7.5 months of age (Figure 4B,C). 
The absence of retinal degeneration in both EpoR knockdown 
strains was confirmed with morphometric analysis of retinal 
thickness in 7.5-month-old mice (Figure 4D). Furthermore, 
ERG recordings pointed to normal retinal function (Figure 
5A,B). Neither the EpoRflox/flox;Opn-Cre mice nor the EpoRflox/
flox;α-Cre mice showed significant changes in a- and b-wave 
amplitudes under scotopic or photopic conditions when 
compared to the control littermates (Figure 5C–E). Taken 
together, these results demonstrate that expression of EpoR 
was not necessary for the correct maturation and function 
of rod photoreceptors and cells in the retinal periphery. In 
addition, long-term survival of the retinal neurons, including 
photoreceptors, was not impaired by the absence of EPOR in 
our knockdown mice.
Lack of the erythropoietin receptor has no influence on 
retinal cell viability in acute hypoxia: The induction of Epo 
expression under hypoxic conditions suggested that this 
cytokine may be particularly important for preserving cell 
viability when oxygen is limited [9,44]. In fact, EPO was 
shown to support neuronal survival against hypoxia-induced 
cell death in vitro [45], and in an in vitro model of cerebral 
ischemia [46]. These findings have been corroborated in vivo 
in a model of brain ischemia/hypoxia [47]. In line with this 
notion, neural cells lacking EpoR showed increased sensitivity 
to hypoxia in vitro [22]. To investigate the ability of EPOR 
to mediate the resistance of retinal cells against hypoxia, 
we exposed 12-week-old EpoR knockdown mice to hypoxia 
(7% O2; 6 h) and analyzed the retinal morphology 12 days 
after the hypoxic exposure to detect potential signs of tissue 
damage. Qualitative investigation of retinal morphology 
did not reveal signs of cell loss upon hypoxic exposure in 
both strains of EpoR knockdown mice when compared to 
the control littermates (Figure 6A, compare to Figure 4A for 
the retinal morphology of normoxic mice). These qualitative 
findings were confirmed with morphometric measurements 
of the retinal thickness, which was comparable to that of the 
normoxic mice (Figure 6B, compare to Figure 4D for retinal 
thickness of normoxic mice). Thus, ablation of EpoR in the 
retinal periphery or in rod photoreceptors does not increase 
retinal susceptibility to acute hypoxia.
Lack of EpoR may alter erythropoietin-erythropoietin 
receptor signaling in the hypoxic retina: EPOR downstream 
signaling activates several signal transduction pathways. 
They may ultimately modulate the transcription of target 
genes involved in various biologic processes, including cell 
growth or apoptosis [48]. Genes shown to be influenced 
by EPO signaling include the antiapoptotic genes B-cell 
lymphoma 2 (Bcl2) and Bcl-2-like 1 (Bcl2l1 [BclXL]) [49,50], 
the proapoptotic genes caspase 1 (Casp1) [19] and apoptotic 
protease activating-factor 1 (Apaf1) [51,52], the neurotrophic 
factor brain-derived neurotrophic factor (Bdnf ) [53], and the 
gliotic response gene glial fibrillary acidic protein (Gfap) 
[54].
To test the influence of EpoR knockdowns on EPO-
EPOR signaling in the retina, we exposed mice at P84 to a 
short period of hypoxia (7% O2, 6 h) and analyzed the gene 
expression immediately thereafter (Figure 7). As expected, 
expression of Epo was increased in all mouse retinas after 
this treatment. Expression of EpoR was not significantly 
affected after hypoxia in both knockdown strains. CRE-
mediated deletion of exons 1–4 of the EpoR gene prevented 
expression of not only EpoR but also sEpoR (Appendix 1) 
[34-36,55]. The expression levels of this isoform were not 
reduced in the EpoRf lox/f lox;Opn-Cre retinas when the total 
retinal RNA was measured. However, sEpoR transcripts 
were significantly (p<0.001) reduced by approximately two 
thirds in the retinas of the EpoRf lox/f lox;α-Cre mice at P84. 
In both knockdown mice strains, hypoxia did not influence 
the expression of sEpoR. Importantly, knockdown of EpoR 
did not lead to compensatory upregulation of Csf2rb (βCR). 
Whereas expression of Bcl2l1 and Bcl2 was not affected by 
the lack of EPOR, Apaf1, Casp1, and Gfap were downregu-
lated and the prosurvival factor Bdnf was upregulated specifi-
cally in the hypoxic retinas (and thus in the presence of the 
increased EPO) of EpoRflox/flox;α-Cre mice (Figure 7B). This 
indicates that lack of EPOR influenced the gene expression 
profile in the hypoxic retinas in ways that suggested reduced 
expression of stress-related genes and increased expression 
of prosurvival genes. These results were unexpected since 
EPO-EPOR signaling is generally accepted to be prosurvival, 
and thus, lack of EPOR should reduce such signaling (see 
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the Discussion section). In contrast to the EpoRflox/flox;α-Cre 
mice, the lack of EPOR in the rods of the EpoRflox/flox;Opn-Cre 
mice did not lead to detectable changes in the gene expres-
sion profile (Figure 7A), suggesting that EPOR signaling may 
affect the inner retinal layers rather than the photoreceptor 
layer.
Ablation of EpoR does not inhibit angiogenesis: Since 
evidence suggests that EPOR signaling is involved in angio-
genesis [56], we investigated whether ablation of EPOR in 
retinal progenitors during development might affect retinal 
vascular development. Using retinal flatmounts and cross-
sections, we did not detect any overt vascular abnormalities 
in the EpoRf lox/f lox;α-Cre mice. In particular, the capillary 
coverage in the retinal periphery was not decreased (Figure 
8A), and all three retinal capillary plexi developed properly 
at their correct location (Figure 8B). Perfusion and stability 
of the retinal vasculature were also not grossly affected as 
revealed with fluorescein angiography and the absence of 
signs of vascular leakage (Figure 8C). As expected, ablation 
Figure 4. Retinal morphology of EpoR knockdown mice. A: Retinal morphology of the EpoRflox/flox, EpoRflox/flox;Opn-Cre and EpoRflox/flox;α-Cre 
mice at P84 and P360. Shown are representative sections of the central retina (EpoRflox/flox and EpoRflox/flox;Opn-Cre) and the peripheral retina 
(EpoRflox/flox;α-Cre) of at least three animals per time point. Scale bar: 50 µm. B, C: Relative expression levels of rhodopsin (Rho), guanine 
nucleotide binding protein alpha transducin 2 (Gnat2), visual system homeobox 2 (Vsx2 (Chx10)), and POU domain, class 4 transcription 
factor 1 (Pou4f1 (Brn3a)) mRNAs as determined with semiquantitative real-time PCR in the total retinas of the EpoRflox/flox;Opn-Cre (B, 
red bars), EpoRflox/flox;α-Cre (C, blue bars), and EpoRflox/flox control littermates (B, C, white bars) at 7.5 months of age. Given are the mean 
± standard deviation (SD) of n = 4 retinas. Values were normalized to actin beta (Actb) and expressed relative to the EpoRflox/flox control 
littermates, in which expression was set to 1. The differences in gene expression levels between the knockdown and control mice at individual 
time points were tested for significance using a Student t test. D: Retinal thickness of 7.5-month-old EpoRflox/flox;Opn-Cre mice (red line), 
EpoRflox/flox;α-Cre mice (blue line), and EpoRflox/flox mice (black line). Thickness was measured at 0, 100, 325, 650, 975, 1300, 1625, and 1950 
μm from the optic nerve head (ONH) in the dorsal and ventral hemispheres, as indicated. Shown are the mean ± SD of n = 3 animals. The 
differences in retinal thickness between the knockdown and control mice were tested for significance using a Student t test.
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of EPOR in mature rod photoreceptors did not lead to any 
detectable differences from the wild-type (Figure 8A–C).
DISCUSSION
Elucidating the expression pattern of EPOR in the retina has 
been the scope of many vision scientists over the past few 
years, and various studies have used immunohistochemistry 
to investigate the expression of EPOR. Unfortunately, the 
commercially available anti-EPOR antibodies have recently 
been shown to give unreliable results, and thus, caution 
should be taken when interpreting these studies [42,43]. In the 
absence of reliable antibodies, the expression of EpoR should 
be analyzed with alternative methods. Colella et al. showed 
with in situ hybridization that EpoR transcripts accumulate 
at elevated levels in the INL and the GCL [57]. Our data on 
the expression of EpoR mRNA in the different retinal nuclear 
layers isolated with laser capture microdissection confirm this 
observation, and most importantly suggest that photorecep-
tors do not express high levels of EpoR. Instead, EpoR may 
be expressed predominantly in the neurons and presumably 
Müller cells of the inner retina (Figure 2). Interestingly, Chen 
and coworkers reported that neural progenitors express higher 
levels of EPOR than mature neurons in the brain [58]. In spite 
of this, we measured increased retinal expression of EpoR 
starting at P10, a time point when differentiation of RPCs 
is completed [59] (Figure 1B). Thus, in the retina, mature 
neurons and glia seemed to express higher levels of EpoR 
compared to the RPCs.
Yu and coworkers showed that EpoR null mice have fewer 
NPCs [22]. Chen et al. made a similar observation in EpoR 
null mice that were rescued with selective EpoR expression 
driven by the endogenous EpoR promoter in hematopoietic 
tissue but not in the brain [58]. This indicates that endogenous 
EPO-EPOR signaling supports cell viability in the embryonic 
brain. However, we did not detect any morphological or func-
tional defects that would hint at developmental abnormalities 
in the retinal periphery of EpoRflox/flox;α-Cre mice (Figure 4A, 
Figure 5). Together, these observations indicated that endog-
enous EPO-EPOR signaling is not crucial for RPC survival 
and development of retinal neurons (RGCs, amacrine, 
Figure 5. Retinal function in EpoR knockdown mice. (A) Scotopic and (B) photopic electroretinogram (ERG) recordings in the EpoRflox/
flox;Opn-Cre and EpoRflox/flox;α-Cre mice and the EpoRflox/flox control littermates. (C) Scotopic a-wave, (D) scotopic b-wave, and (E) photopic 
b-wave amplitudes plotted as a function of light intensity. Shown are the mean ± standard deviation (SD) of n = 3 animals per genotype. 
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horizontal, and photoreceptor cells) and glia (Müller cells), at 
least not in the retinal periphery. Furthermore, the absence of 
tangible signs of retinal degeneration in the retinal periphery 
of 1-year-old EpoRflox/flox;α-Cre retinas suggested that EPOR 
Figure 6. Retinal morphology of EpoR knockdown mice exposed to hypoxia. A: Retinal morphology of the EpoRflox/flox, EpoRflox/flox;Opn-Cre, 
and EpoRflox/flox;α-Cre mice analyzed 12 days after they were exposed to hypoxia (7% O2, 6 h). Shown are representative sections of the 
central retina (EpoRflox/flox and EpoRflox/flox;Opn-Cre mice) or the peripheral retina (EpoRflox/flox;α-Cre mice) of three animals per time point. 
Scale bar: 50 µm. B: Thickness of the retinas of the EpoRflox/flox (black line), EpoRflox/flox;Opn-Cre, (red line), and EpoRflox/flox;α-Cre (blue line) 
mice. Thickness was measured 12 days after the mice were exposed to hypoxia (7% O2, 6 h) at 0, 100, 325, 650, 975, 1300, 1625, and 1950 
μm from the optic nerve head (ONH) in the dorsal and ventral hemispheres, as indicated. Shown are the mean ± standard deviation (SD); n 
= 3. The differences in retinal thickness between the knockdown and control mice were tested for significance using a Student t test. 
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signaling is also not necessary for the survival of retinal cells 
under non-pathological conditions.
The absence of any detectable consequence of EpoR 
knockdown in rod photoreceptors may be explained by the 
low expression level of EpoR in the ONL (Figure 2). This also 
suggests that EPOR may not be directly involved in photore-
ceptor physiology and survival, a conclusion supported by the 
integrity of the retinal tissue in aging EpoRf lox/flox;Opn-Cre 
mice (Figure 4A).
In addition to the membrane-bound isoform, we also 
detected retinal expression of sEpoR, as has been previously 
reported for the brain [60]. Expression of sEpoR in the post-
natal retinas of wild-type mice followed a profile remarkably 
similar to the membrane-bound isoform of EpoR (Figure 1C). 
This is interesting regarding the proposed function of sEPOR. 
Based on a study published by Soliz et al., sEPOR may act as 
a negative regulator of EPO signaling. The soluble isoform 
consists of the extracellular domain and binds EPO, therefore 
sequestering the cytokine and preventing it from binding 
to the membrane-bound EPOR, and thus from activating 
intracellular signaling cascades [60,61]. Soluble receptors 
frequently modulate cytokine signaling by stabilizing the 
cytokine, changing its tissue concentration, or modifying its 
interaction with the membrane-bound receptor [62,63]. For 
example, intravitreal injection of sEPOR in a rat model of 
retinal detachment led to increased photoreceptor apoptosis 
[64], and coapplication of EPO and sEPOR blocked the 
protective effects of EPO in an in vitro model of cerebral 
ischemia [46]. The soluble form of EPOR could have a similar 
function in the retina and abrogate EPO-EPOR signaling by 
Figure 7. Expression of selected genes in the retinas of EpoR knockdown mice. A, B: Relative quantification of erythropoietin (Epo), 
erythropoietin receptor (EpoR), soluble erythropoietin receptor (sEpoR), beta common receptor (Csf2rb (βCR)), B cell lymphoma 2 (Bcl2), 
Bcl2-like 1 (Bcl2l1(BclXL)), apoptotic protease activating factor 1 (Apaf1), brain-derived neurotrophic factor (Bdnf ), caspase 1 (Casp1), 
and glial fibrillary acidic protein (Gfap) gene expression in the retinas of the EpoRflox/flox;Opn-Cre (A) and the EpoRflox/flox;α-Cre mice (B) 
compared to EpoRflox/flox control littermates with real-time PCR. cDNAs were prepared from total retinal RNA isolated at P84. Animals were 
kept under normoxic conditions (N) or exposed to hypoxia (H, 7% O2, 6 h) immediately before euthanasia and retina isolation. Given are 
the mean ± standard deviation (SD) for n = 4 retinas. Values were normalized to actin beta (Actb) and expressed relative to the EpoRflox/flox 
control littermates under normoxic conditions, which were set to 1. The differences in gene expression levels between the knockdown and 
control mice at individual time points and conditions were tested for significance using a Student t test *: p<0.05; **: p<0.01; ***: p<0.001.
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sequestering endogenous EPO. As a consequence, EPO-
EPOR signaling in the retina may occur only under condi-
tions where EPO protein levels are elevated, such as under 
hypoxia or upon exogenous EPO applications. Intriguingly, 
the expression of sEpoR in the brain and plasma has been 
reported to be reduced in hypoxia [60,65], thus allowing 
advanced modulation of the EPO response under these condi-
tions. However, similar downregulation of sEpoR expression 
was not observed in the retina after acute hypoxia (Figure 
7). Either the hypoxic period was too short to cause down-
regulation of sEpoR, or regulation of sEPOR synthesis is not 
controlled at the transcriptional level in the retina.
To understand the regulatory function of sEPOR, the 
retinal cell populations that express each isoform must be 
identified. Ablation of EpoR in the retinal periphery of 
the EpoRf lox/f lox;α-Cre mice caused a strong and signifi-
cant decrease in the sEpoR transcript levels of about two 
thirds, whereas EpoR expression decreased only by roughly 
one third (Figures 3B, 7B). Based on this observation, we 
deduced that the population of cells that was CRE-positive 
in the EpoRflox/flox;α-Cre retina was expressing elevated levels 
of sEpoR in the wild-type retina under normal conditions. 
Due to the heterogeneous population of cells undergoing 
CRE-mediated recombination in the α-Cre mouse retina, it 
is difficult to make any assumptions about the identity of 
the retinal cell types that express sEpoR. Nevertheless, based 
on the unaltered expression of sEpoR in the retinas of the 
EpoRflox/flox;Opn-Cre mice (Figure 7A), we suggest that rod 
photoreceptors do not significantly participate in the secre-
tion of sEPOR.
We did not measure significant changes in gene expres-
sion in the normoxic or hypoxic retinas of the EpoRf lox/
flox;Opn-Cre mice (Figure 7A). The relatively low expression 
of EpoR in the ONL of the EpoRflox/flox;Opn-Cre mice could 
explain this observation. The gene expression profile in the 
EpoRf lox/f lox;α-Cre knockdown mice, however, gave unex-
pected results. Several genes (Apaf1, Casp1, Gfap) that had 
been expected to show increased expression in the absence 
Figure 8. Retinal vasculature and 
vascular perfusion in the EpoR 
knockdown mice. A: Retinal flat-
mounts of EpoRflox/flox and EpoRflox/
flox;Opn-Cre littermates at P84 and 
of the EpoRflox/flox;α-Cre mice at P30. 
Vessels were stained with isolectin 
IB4 coupled to Alexa 594. Shown 
are representative f latmounts of 
three animals per genotype. Scale 
bar: 500 µm. B: Staining of blood 
vessels on retinal cryosections 
(isolectin IB4, coupled to Alexa 
594) in the EpoRf lox/f lox, EpoRf lox/
flox;Opn-Cre, and EpoRflox/flox;α-Cre 
mouse retinas at P84. Vessels were 
highlighted with artificial coloring 
(primary plexus (P): red; interme-
diate plexus (I): green; outer plexus 
(O): blue). Cell nuclei were stained 
with 4’,6-diamidino-2-phenylindole 
dihydrochloride (DAPI) (white). 
Scale bar: 100 µm. C: Fluorescein 
angiography of the EpoRf lox/f lox, 
EpoRflox/flox;Opn-Cre, and EpoRflox/
f lox;α-Cre mouse retinas at P84 
performed with Micron III imaging. 
Shown are representative images of 
three animals per genotype. 
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of EPOR were in fact expressed at lower levels in the hypoxic 
retinas of these mice. The opposite was true for genes that 
had been expected to be downregulated in EpoRflox/flox;α-Cre 
mice (Bdnf; Figure 7B). The reduced expression of sEpoR in 
the retinas of the EpoRflox/flox;α-Cre mice may explain these 
surprising results. Cells not affected by EpoR ablation (cells 
that do not express CRE) could show increased EPO-EPOR 
signaling due to potentially reduced levels of extracellular 
sEPOR. The diminished presence of sEPOR would result in 
reduced sequestration of EPO, thus allowing augmented acti-
vation of the membrane-bound EPOR and downstream target 
genes. However, this hypothesis is speculative and clearly 
needs additional support with experimental data. Analysis 
of gene and protein expression in mice with efficient knock-
down of EpoR in a single retinal cell type would be needed to 
specifically determine the influence of EPO-EPOR signaling 
on retinal physiology. Alternatively, the consequences of the 
absence of EPOR in the retina could be studied in EpoR null 
mice that are rescued by selective EpoR expression in hema-
topoietic tissue but not in the neural cells [58].
The angiogenic activity of EPO during development 
may be related to the stimulation of endothelial progenitor 
cell mobilization or proliferation [66]. Expression of EpoR 
has been detected in various types of vascular endothelial 
cells [67], and it is therefore assumed that the angiogenic 
activities of EPO are directly mediated through binding to 
EPOR expressed on the surface of vascular endothelial cells. 
In the α-Cre mouse, Cre recombinase is not expressed in 
retinal vascular endothelial cells [68]. Therefore, it may not 
be surprising that the retinal vasculature did not show any 
signs of developmental defects. Nevertheless, we also ruled 
out indirect effects suggesting that the EPO-EPOR system 
in RGCs, amacrine, horizontal, and Müller cells does not 
significantly contribute to the development of the vasculature 
in the retinal periphery. However, it would be of great interest 
to specifically ablate EpoR in vascular cells and analyze the 
retinal vasculature under these conditions.
Based on data presented in this study, we conclude that 
EPOR is not required for the development and long-term 
survival of retinal neurons (RGCs, amacrine, horizontal, and 
rod photoreceptor cells) and glia (Müller cells) in the retinal 
periphery. The parallel longitudinal expression profile of 
EpoR and sEpoR in the postnatal retina suggests that EPO-
EPOR signaling may not be constantly activated in this neural 
tissue.
APPENDIX 1. SPECIFICITY OF PRIMERS 
FOR ERYTHROPOIETIN RECEPTOR (EPOR) 
ISOFORMS.
Schematic diagram representing the mRNA structure (exon 4 
to 6 are shown) of EpoR and soluble EpoR (sEpoR). Primers 
specific to EpoR bind to exon 5 (EpoR forward) and to the 
exon 5 – exon 6 junction (EpoR reverse). Primers specific 
to sEpoR bind to exon 4 (sEpoR forward) and to the exon 
5 – exon 5a junction (sEpoR reverse). Exon 5a corresponds to 
intron 5, which is retained in sEpoR mRNA and contains an 
in-frame stop codon that results in the translation of EPOR 
lacking the transmembrane and cytosolic domains [69]. To 
access the data, click or select the words “Appendix 1.”
APPENDIX 2. ASSESSMENT OF CROSS-
CONTAMINATION BY SEMIQUANTITATIVE 
REAL-TIME PCR OF RETINAL LAYERS 
ISOLATED BY LASER CAPTURE 
MICRODISSECTION.
(A) POU domain, class 4, transcription factor 1 (Pou4f1 
(Brn3a)), a marker for the ganglion cell layer. (B) visual 
system homeobox 2 (Vsx2 (Chx10)), a marker for the inner 
nuclear layer. (C) Guanine nucleotide binding protein, alpha 
transducin 1 (Gnat1), a marker for the outer nuclear layer. 
Tissue was isolated from of EpoRflox/flox;Opn-Cre, and EpoR-
f lox/f lox control littermates. Values were normalized to actin 
beta (Actb) and expressed relatively to the value of EpoRflox/
flox in the ONL, which was set to 1. Shown are mean values 
± SD of at least 2 different mice. ONL, outer nuclear layer; 
INL, inner nuclear layer; GCL, ganglion cell layer. To access 
the data, click or select the words “Appendix 2.”
APPENDIX 3. LOCALIZATION OF CRE 
ACTIVITY IN THE RETINA OF AI6;Α-CRE 
REPORTER MICE.
(A) Retinal cryosection of Ai6;α-Cre mice (cut naso-temporal) 
at post-natal day (PND) 15. ZSGREEN fluorescence (green) 
indicates cells that underwent CRE mediated recombination. 
Inset (A1) shows a higher magnification of the transition zone 
between central and peripheral retina. Scale bars: 200 μm and 
50 µm (inset). (B) Identification of CRE-expressing retinal 
cells by the co-localization of ZSGREEN and different cell 
markers in Ai6;α-Cre mice at PND 15. Shown are retinal 
cryosections presenting native ZSGREEN fluorescence after 
CRE-mediated recombination (green) and immunostainings 
for different retinal cell markers (red) as indicated. POU 
domain, class 4, transcription factor 1 (POU4F1 (BRN3A)) 
for retinal ganglion cells (RGCs); calbindin 1 (CALB1) for 
horizontal cells and a subset of amacrine cells; calbindin 2 
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(CALB2) for amacrine cells and a subset of ganglion cells; 
glutamate-ammonia ligase (GLUL (GS)) for Müller cells; 
glial fibrillary acidic protein (GFAP) for astrocytes and 
activated Müller cells; visual system homeobox 2 (VSX2 
(CHX10)) for bipolar cells; protein kinase C alpha (PKCA) 
for rod bipolar cells; retinal pigment epithelium-specific 
65 kDa protein (RPE65) for the retinal pigment epithelium. 
Scale bar: 100 μm. RPE: retinal pigment epithelium; ONL: 
outer nuclear layer; OPL: outer plexiform layer; INL: inner 
nuclear layer; IPL: inner plexiform layer; GCL: ganglion cell 
layer; D: dorsal; V: ventral. To access the data, click or select 
the words “Appendix 3.”
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